[pubmed] Inflammatory myositis in cancer patients receiving immune checkpoint inhibitors

[RSS-Bot]

Arthritis Rheumatol. 2021 Mar 7. doi: 10.1002/art.41714. Online ahead of print.

ABSTRACT

We thank Dr. Suzuki for his comments. His personal and firsthand experience expands on our increasing knowledge of immune checkpoint inhibitor (ICI)-induced myositis and ICI-myasthenia gravis (MG) from a clinical and laboratory perspective. We agree with observations made in Japanese patients, that accompanying MG in these ICI-myositis patients is difficult to tease out clinically, by electrodiagnostic evaluation (except via single-fiber electromyography-SFEMG) and laboratory investigations.

PMID:33682370 | DOI:10.1002/art.41714


Source: https://pubmed.ncbi.nlm.nih.gov/3368237 ... 8&v=2.14.2